Code
|
6715D
|
MA number
|
EU/1/08/442/031
|
Product Form:
|
pqo por 30x180,4 mg+solv.28 ml+70 mg sukral.pr. (vre.PET/Al/LDPE+fľ.skl.)
|
MA Status:
|
E - Valid centralised marketing authorisation
|
Type of procedure:
|
EU
|
MAH, country:
|
Boehringer Ingelheim International GmbH, Germany
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
ATC:
|
B |
BLOOD AND BLOOD FORMING ORGANS |
B01 |
ANTITHROMBOTIC AGENTS |
B01A |
ANTITHROMBOTIC AGENTS |
B01AE |
DIRECT THROMBIN INHIBITORS |
B01AE07 |
Dabigatran etexilate |
|
Shelf life:
|
36 |
Route of admin.:
|
Oral use
|